- Home
- ESPR vs SMTI Comparison
ESPR vs SMTI Comparison
Compare ESPR & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- SMTI
- Stock Information
- Founded
- ESPR 2008
- SMTI 1982
- Country
- ESPR United States
- SMTI United States
- Employees
- ESPR N/A
- SMTI N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- SMTI Medical/Dental Instruments
- Sector
- ESPR Health Care
- SMTI Health Care
- Exchange
- ESPR Nasdaq
- SMTI Nasdaq
- Market Cap
- ESPR 220.0M
- SMTI 243.3M
- IPO Year
- ESPR 2013
- SMTI N/A
- Fundamental
- Price
- ESPR $2.17
- SMTI $33.95
- Analyst Decision
- ESPR Buy
- SMTI Strong Buy
- Analyst Count
- ESPR 6
- SMTI 2
- Target Price
- ESPR $6.50
- SMTI $50.00
- AVG Volume (30 Days)
- ESPR 5.2M
- SMTI 45.7K
- Earning Date
- ESPR 08-05-2025
- SMTI 08-13-2025
- Dividend Yield
- ESPR N/A
- SMTI N/A
- EPS Growth
- ESPR N/A
- SMTI N/A
- EPS
- ESPR N/A
- SMTI N/A
- Revenue
- ESPR $268,125,000.00
- SMTI $97,241,894.00
- Revenue This Year
- ESPR $6.10
- SMTI $22.70
- Revenue Next Year
- ESPR N/A
- SMTI $13.56
- P/E Ratio
- ESPR N/A
- SMTI N/A
- Revenue Growth
- ESPR N/A
- SMTI 34.29
- 52 Week Low
- ESPR $0.69
- SMTI $23.53
- 52 Week High
- ESPR $3.94
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- ESPR 73.45
- SMTI 70.30
- Support Level
- ESPR $2.00
- SMTI $29.33
- Resistance Level
- ESPR $2.14
- SMTI $32.25
- Average True Range (ATR)
- ESPR 0.15
- SMTI 1.73
- MACD
- ESPR 0.02
- SMTI 0.75
- Stochastic Oscillator
- ESPR 95.08
- SMTI 94.75
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.